NEW YORK and LONDON, March 7th, 2017 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that …
[Read more...] about Akari Therapeutics to Present at the 29th Annual ROTH Conference
PRESS RELEASES
Akari Therapeutics to Attend Upcoming Investor Conferences in February
NEW YORK and LONDON, January 31st, 2017 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that …
[Read more...] about Akari Therapeutics to Attend Upcoming Investor Conferences in February
Akari Therapeutics Expands Clinical and Regulatory Teams with Industry Veterans
NEW YORK and LONDON, January 4th, 2017 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, has expanded its …
[Read more...] about Akari Therapeutics Expands Clinical and Regulatory Teams with Industry Veterans
